Quick Answer
DNA X, Inc. reported Total Assets of $39.74 million for the year ending 2024.
- DNA X, Inc. showed a decrease of -29.1% in Total Assets from 2023 to 2024.
- This data is from DNA X, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $61.94 million | Q2 2019: $85.91 million | Q3 2019: $68.97 million | Q1 2020: $46.01 million | Q2 2020: $71.45 million | Q3 2020: $62.38 million | Q1 2021: $40.75 million | Q2 2021: $40.87 million | Q3 2021: $38.19 million | Q1 2022: $39.30 million | Q2 2022: $37.29 million | Q3 2022: $46.00 million | Q1 2023: $51.80 million | Q2 2023: $53.74 million | Q3 2023: $58.61 million | Q1 2024: $42.39 million | Q2 2024: $45.87 million | Q3 2024: $49.15 million | Q4 2024: $39.74 million | Q1 2025: $35.96 million | Q2 2025: $36.08 million | Q3 2025: $40.22 million.
- Over the full 7 years of available data (2018 to 2024), DNA X, Inc.'s Total Assets has declined by 41.0%.
- Historical annual values: Fiscal year 2024: $39.74 million | Fiscal year 2023: $56.04 million | Fiscal year 2022: $53.69 million | Fiscal year 2021: $41.09 million | Fiscal year 2020: $50.31 million | Fiscal year 2019: $55.46 million | Fiscal year 2018: $67.35 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: